Search alternatives:
significant component » significant amount (Expand Search)
component increases » content increases (Expand Search), component includes (Expand Search), complexity increases (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 21 - 40 results of 28,857 for search '(( significant ((point decrease) OR (mean decrease)) ) OR ( significant component increases ))', query time: 1.23s Refine Results
  1. 21
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 22
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 23
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 24
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 25
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 27
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    Relish SUMOylation decreases its transcriptional activity.

    Relish SUMOylation decreases its transcriptional activity. by Ruijuan Tang (11250680)

    Published 2021
    Save to List
    Saved in:
  14. 34
    Mean standard errors across time points for the outcome of social stigma.

    Mean standard errors across time points for the outcome of social stigma. by Ana Beato (20489933)

    Published 2024
    Save to List
    Saved in:
  15. 35
    Means with standard errors across time points for the outcome of social distance.

    Means with standard errors across time points for the outcome of social distance. by Ana Beato (20489933)

    Published 2024
    Save to List
    Saved in:
  16. 36
    Means with standard errors across time points for the outcome of intergroup anxiety.

    Means with standard errors across time points for the outcome of intergroup anxiety. by Ana Beato (20489933)

    Published 2024
    Save to List
    Saved in:
  17. 37
    Mean value of ENSS and subscales.

    Mean value of ENSS and subscales. by Phu Dinh Vu (19429477)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 38
    Points extracted from image.

    Points extracted from image. by Mestewat Simeon (19233200)

    Published 2024
    “…The MK tests show a decreasing trend for both mean annual and main rainy season rainfall, with Sen’s slope (β) = -0.721 and β = -0.1.23, respectively. …”
    Save to List
    Saved in:
  19. 39
    Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B).

    Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B). by Tra-My Duong-Nu (7300970)

    Published 2019
    Save to List
    Saved in:
  20. 40
    Loss of SID-1 and/or SID-3 functionality decreases DA neurodegeneration and improves DA neuron function.

    Loss of SID-1 and/or SID-3 functionality decreases DA neurodegeneration and improves DA neuron function. by Anthony L. Gaeta (13272609)

    Published 2022
    Save to List
    Saved in:

Search Tools: